Anika Therapeutics reported $328K in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US USD 2.5B 703M
Agenus AGEN:US USD -39945000 3.34M
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Arrowhead Research ARWR:US USD -81170000 10.86M
Clovis Oncology CLVS:US USD -42347000 15.13M
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Immunogen IMGN:US USD -77005000 16.41M
Insmed INSM:US USD -119864000 21.78M
Integra Lifesciences IART:US USD 105.32M 2.51M
Intrexon XON:US USD -5899000 15.79M
Johnson & Johnson JNJ:US USD 7.81B 876M
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Macrogenics MGNX:US USD -22111000 16.82M
Merit Medical Systems MMSI:US USD 52.14M 2.03M
Peregrine Pharmaceuticals PPHM:US USD 4.34M 1.85M
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Smith & Nephew PLC SN/:LN 644M 21M
Stryker SYK:US USD 1.09B 64M
Veracyte VCYT:US USD -3356000 2.42M
Xencor XNCR:US USD -36110000 10.33M
Zimmer Biomet Holdings Inc ZBH:US USD 524.9M 51M